CCT-102 or Expectant Management in Delayed Pregnancy Loss

PHASE3CompletedINTERVENTIONAL
Enrollment

183

Participants

Timeline

Start Date

July 21, 2023

Primary Completion Date

May 15, 2025

Study Completion Date

July 30, 2025

Conditions
Early Pregnancy Loss, Delayed Pregnancy Loss
Interventions
COMBINATION_PRODUCT

CCT-102 A and CCT-102 B

2 day oral regimen

Trial Locations (15)

10032

Columbia University Irving Medical Center, New York

10461

Montefiore Medical Center, The Bronx

17033

Penn State Hershey Obstetrics and Gynecology, Hershey

21215

Sinai Hospital of Baltimore, Baltimore

23456

Tidewater Clinical Research, Virginia Beach

27103

Lyndhurst Clin Research, Winston-Salem

28562

Eastern Carolina Women's Center, PA, New Bern

32405

Emerald Coast Obstetrics and Gynecology, Panama City

67226

Cypress Medical Research Center, Wichita

75067

Prime Clinical Research - Lewisville North Valley, Lewisville

77555

The University of Texas Medical Branch at Galveston, Galveston

77573

Maximos Obstetrics & Gynecology, League City

85704

Noble Clinical Research, Tucson

89030

Las Vegas Clinical Trials, Las Vegas

91340

Amicis Research Center, LLC, San Fernando

Sponsors
All Listed Sponsors
lead

Conceptra Biosciences, LLC

INDUSTRY